Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
89bio, Inc. | Director | Stock Option (Right to Buy) | 45.2K | Feb 1, 2024 | Direct | ||
iTeos Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 22.4K | Jun 13, 2023 | Direct | ||
Mineralys Therapeutics, Inc. | Director | Stock Option | 22K | May 22, 2024 | Direct | ||
Acrivon Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 20.3K | Jun 20, 2024 | Direct | ||
Werewolf Therapeutics, Inc. | Director | Stock Option (right to buy) | 17.5K | May 24, 2024 | Direct |